Clinical Trial Update: Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating whether nebulized lidocaine attenuates the hemodynamic response to double-lumen endotracheal intubation in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms

Drugs mentioned

• Nebulized lidocaine (lidocaine)

Snippet

Sponsor: RenJi Hospital | Conditions: Lung Neoplasms | Phase 4 | Status: UNKNOWN